Human longevity is heritable, and statistically and biologically compelling genetic associations with longevity and age-related traits in humans have been identified. The translation of these genetic associations into insights that can lead to pharmacological interventions designed to promote healthy aging requires an approach and infrastructure that integrates many sources of information and scientific expertise. In fact, a previous inability to translate insights from genetic associations to longevity-promoting interventions is due, at least in part, to a lack of well-integrated and assembled research teams with expertise in all areas of relevance. We propose the creation of a resource and infrastructure that integrates genomic and related data sources that enable our diverse scientific team to develop strategies for identifying targets for pharmacological intervention that will impact longevity based on genetic associations. This infrastructure will include information from longitudinal cohort studies with genome-wide genotype and sequencing data, computational methods for annotating genetic variants, information from tissue-specific studies of expression quantitative trait loci (eQTL), and datasets of chemical properties of small molecule compounds linked to protein targets. Our scientific team includes experts in human and model organism aging, genetic epidemiology of aging, statistical genetics, chemical informatics, and pharmaceutical development. We will also assemble a research planning committee that will meet annually to evaluate the evidence from our statistical analyses and to develop plans for pilot projects to advance the translation of our findings into health-promoting therapeutics. A central theme in our proposal is to develop insights relating molecular and physiologic factors that can be manipulated pharmacologically to healthy aging based on hypothesis rooted in genetic associated studies involving longevity. We will identify candidate genetic variants for in-depth analysis by meta-analyzing results from published genome-wide association studies (GWAS) of longevity and age-related traits and by searching for evidence of genetic variants with pleiotropic effects on aging-related traits. Genes likely to be modulated by candidate genetic variants will be identified using genomic functional annotation resources such as tissue-specific genomic functional elements and eQTLs. For each identified gene, an allelic series of genetic variants associated with, e.g., the expression of that gene, will be identified from eQTL data sets, and a genetic risk score constructed from the allelic series will be tested for its association with longitudinal measures of aging, including incident disability, incident disease and chronic conditions, and change in physical and cognitive function, which can build the foundation for the search for small molecule compounds that might mimic the collective effect of selected genetic variants. By identifying small molecules based on therapeutic hypotheses relating genetic function to healthy aging, effective translational research strategies can be developed and disseminated to the research community.

Public Health Relevance

Translation of genetic associations into insights that can lead to pharmacological interventions designed to promote healthy aging requires an approach and infrastructure that integrates many sources of information and scientific expertise. We propose the creation of an infrastructure and an integrated data system to enable our team of scientists to develop therapeutic research strategies based on causal connections between molecular traits and healthy aging, and chemicals that target the molecular traits. Therapeutics that can promote healthy aging can have a great impact on the elderly, a rapidly growing subgroup of our population.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
5U24AG051129-02
Application #
9138960
Study Section
Special Emphasis Panel (ZAG1)
Program Officer
Rossi, Winifred K
Project Start
2015-09-15
Project End
2020-04-30
Budget Start
2016-06-01
Budget End
2017-04-30
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
California Pacific Medical Center Research Institute
Department
Type
DUNS #
071882724
City
San Francisco
State
CA
Country
United States
Zip Code
94107
Buckley, Alexandra R; Ideker, Trey; Carter, Hannah et al. (2018) Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas. Genome Med 10:69
Schork, Nicholas J; Raghavachari, Nalini; Workshop Speakers and Participants (2018) Report: NIA workshop on translating genetic variants associated with longevity into drug targets. Geroscience 40:523-538
Ding, Kuan-Fu; Finlay, Darren; Yin, Hongwei et al. (2018) Network Rewiring in Cancer: Applications to Melanoma Cell Lines and the Cancer Genome Atlas Patients. Front Genet 9:228
Ding, Kuan-Fu; Petricoin, Emanuel F; Finlay, Darren et al. (2018) Nonlinear mixed effects dose response modeling in high throughput drug screens: application to melanoma cell line analysis. Oncotarget 9:5044-5057
Schork, N J; Nazor, K (2017) Integrated Genomic Medicine: A Paradigm for Rare Diseases and Beyond. Adv Genet 97:81-113
Zillikens, M Carola; Demissie, Serkalem; Hsu, Yi-Hsiang et al. (2017) Large meta-analysis of genome-wide association studies identifies five loci for lean body mass. Nat Commun 8:80
Ding, Kuan-Fu; Finlay, Darren; Yin, Hongwei et al. (2017) Analysis of variability in high throughput screening data: applications to melanoma cell lines and drug responses. Oncotarget 8:27786-27799
Backman, Tyler William H; Evans, Daniel S; Girke, Thomas (2017) Large-scale bioactivity analysis of the small-molecule assayed proteome. PLoS One 12:e0171413
Ben-Avraham, Dan; Karasik, David; Verghese, Joe et al. (2017) The complex genetics of gait speed: genome-wide meta-analysis approach. Aging (Albany NY) 9:209-246
Willems, Sara M; Wright, Daniel J; Day, Felix R et al. (2017) Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness. Nat Commun 8:16015

Showing the most recent 10 out of 14 publications